SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

NCT07096999 · clinicaltrials.gov ↗

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Carcinoma

Interventions

OTHER: Non-Interventional Study

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]